Expanded Access for Mezigdomide

Sponsor
Bristol-Myers Squibb
Study ID
NCT06994117
Status
Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an expanded access designed to provide access to Mezigdomide for eligible participants.

Key Dates

Status verified
Dec 2025

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain the NCT# and Site #.